NO994823L - Benzocykloheptatiofenforbindelser - Google Patents

Benzocykloheptatiofenforbindelser

Info

Publication number
NO994823L
NO994823L NO994823A NO994823A NO994823L NO 994823 L NO994823 L NO 994823L NO 994823 A NO994823 A NO 994823A NO 994823 A NO994823 A NO 994823A NO 994823 L NO994823 L NO 994823L
Authority
NO
Norway
Prior art keywords
analogs
compounds
substituted
cycloheptal
carboxyalkyloxyalkyl
Prior art date
Application number
NO994823A
Other languages
English (en)
Other versions
NO994823D0 (no
NO311934B1 (no
Inventor
A K Gunnar Aberg
George E Wright
Jan L Chen
Original Assignee
Bridge Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bridge Pharma Inc filed Critical Bridge Pharma Inc
Publication of NO994823D0 publication Critical patent/NO994823D0/no
Publication of NO994823L publication Critical patent/NO994823L/no
Publication of NO311934B1 publication Critical patent/NO311934B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19994823A 1997-04-03 1999-10-04 Benzocykloheptatiofenforbindelser NO311934B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4390597P 1997-04-03 1997-04-03
PCT/US1998/006576 WO1998043640A1 (en) 1997-04-03 1998-04-02 Benzocycloheptathiophene compounds

Publications (3)

Publication Number Publication Date
NO994823D0 NO994823D0 (no) 1999-10-04
NO994823L true NO994823L (no) 1999-10-07
NO311934B1 NO311934B1 (no) 2002-02-18

Family

ID=21929513

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994823A NO311934B1 (no) 1997-04-03 1999-10-04 Benzocykloheptatiofenforbindelser

Country Status (18)

Country Link
US (1) US6207683B1 (no)
EP (1) EP0977568B1 (no)
JP (1) JP2001519789A (no)
KR (1) KR20010005791A (no)
CN (1) CN1128789C (no)
AT (1) ATE319450T1 (no)
AU (1) AU733325B2 (no)
BR (1) BR9807911A (no)
CA (1) CA2283663C (no)
DE (1) DE69833748T2 (no)
HK (1) HK1027961A1 (no)
ID (1) ID24487A (no)
IL (1) IL131999A (no)
NO (1) NO311934B1 (no)
NZ (1) NZ337843A (no)
PL (1) PL336007A1 (no)
RU (1) RU2193557C2 (no)
WO (1) WO1998043640A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
EP1218007B1 (en) 1999-09-13 2011-07-20 Bridge Pharma, Inc. Optically active isomers of ketotifen and therapeutically active metabolites thereof
US20100166804A1 (en) * 2007-05-23 2010-07-01 Dennis Penn Methods
WO2009096080A1 (ja) * 2008-01-30 2009-08-06 Nippon Zoki Pharmaceutical Co., Ltd. ピペリジン誘導体
WO2009142772A2 (en) 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
JP5083989B2 (ja) * 2008-11-20 2012-11-28 日本臓器製薬株式会社 ピペリジン誘導体を含有する医薬
WO2010107525A1 (en) * 2009-03-17 2010-09-23 Aciex Therapeutics, Inc. Ophthalmic formulations of ketotifen and methods of use
CN103619839B (zh) * 2011-06-28 2016-06-01 福建省闽东力捷迅药业有限公司 抗-***反应的苯并环庚并噻吩衍生物
US8557846B1 (en) 2012-10-23 2013-10-15 Bridge Pharma, Inc. Medicinal treatment of dermal diseases in dogs
US8778971B2 (en) 2012-10-23 2014-07-15 Bridge Pharma, Inc. Medicinal treatment of dermal diseases in companion animals
US20150272941A1 (en) 2012-10-30 2015-10-01 Bridge Pharma, Inc. Medicinal treatment of chronic pulmonary inflammatory diseases with norketotifen
US20140120121A1 (en) 2012-10-30 2014-05-01 Bridge Pharma, Inc. Medicinal treatment of atopic inflammatory diseases
US9439895B2 (en) 2013-08-06 2016-09-13 Bridge Pharma, Inc. Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients
US9345697B2 (en) 2013-08-06 2016-05-24 Bridge Pharma, Inc. Methods of treatment of non-histaminic pruritus
US9138431B2 (en) 2013-08-06 2015-09-22 Bridge Pharma, Inc. Methods of treatment of histamine H-4 receptor-related pruritus
CN104045633B (zh) * 2014-06-26 2017-07-21 福建省闽东力捷迅药业有限公司 一种富马酸卢帕替芬晶型a及其制备方法
CN104031035B (zh) * 2014-06-26 2017-08-25 福建省闽东力捷迅药业有限公司 一种富马酸卢帕替芬混晶及其制备方法
ES2703693T3 (es) * 2015-06-11 2019-03-12 Bridge Pharma Inc Métodos de tratamiento del prurito no histamínico en mamíferos
JP2019529541A (ja) 2016-09-08 2019-10-17 エマーゴ セラピューティクス，インク． 高サイトカイン血症及びウィルス感染の処置の為の肥満細胞安定剤
WO2018075574A1 (en) 2016-10-18 2018-04-26 Emergo Therapeutics, Inc. Mast cell stabilizers for treatment of chronic inflammatory conditions
CN109180666A (zh) * 2018-09-07 2019-01-11 福建省闽东力捷迅药业有限公司 一种富马酸卢帕替芬的杂质c及其制备方法和检测方法
CN115960135A (zh) * 2022-07-21 2023-04-14 华创合成制药股份有限公司 抗组胺类化合物及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470263A1 (de) * 1963-12-19 1969-05-29 Sandoz Ag Neue Heterocyclische Verbindungen und Verfahren zu ihrer Herstellung
DE2626583A1 (de) * 1975-06-24 1977-01-13 Sandoz Ag Neue benzocycloheptathiophenderivate ihre herstellung und ihre verwendung als heilmittel
US4355036A (en) * 1980-06-19 1982-10-19 Schering Corporation Tricyclic-substituted piperidine antihistamines
US5250681A (en) 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same

Also Published As

Publication number Publication date
EP0977568A4 (en) 2001-03-21
NO994823D0 (no) 1999-10-04
CA2283663A1 (en) 1998-10-08
HK1027961A1 (en) 2001-02-02
NO311934B1 (no) 2002-02-18
US6207683B1 (en) 2001-03-27
BR9807911A (pt) 2000-02-22
CN1128789C (zh) 2003-11-26
NZ337843A (en) 2001-11-30
CA2283663C (en) 2006-07-25
EP0977568B1 (en) 2006-03-08
DE69833748D1 (de) 2006-05-04
AU733325B2 (en) 2001-05-10
EP0977568A1 (en) 2000-02-09
WO1998043640A1 (en) 1998-10-08
JP2001519789A (ja) 2001-10-23
KR20010005791A (ko) 2001-01-15
PL336007A1 (en) 2000-06-05
ATE319450T1 (de) 2006-03-15
IL131999A (en) 2004-06-20
CN1258219A (zh) 2000-06-28
ID24487A (id) 2000-07-20
RU2193557C2 (ru) 2002-11-27
DE69833748T2 (de) 2006-11-23
IL131999A0 (en) 2001-03-19
AU6881298A (en) 1998-10-22

Similar Documents

Publication Publication Date Title
NO994823D0 (no) Benzocykloheptatiofenforbindelser
EE9900413A (et) Medikamentide kontrollitud väljutamine silma eeskambrisse
BG106586A (en) Pyrazolopyramidines as therapeutic agents
SE9504661D0 (sv) New compounds
LU90987I2 (fr) Copaxone et ses dérivés pharmaceutiquement acceptables
ATE240344T1 (de) Nor-pregnane zur induzierung hypothalamischer effekte
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
EP0781561A4 (en) NEW MEDICAL USE OF A 5HT 3 ANTAGONIST?
IL143105A0 (en) Fused polycyclic heterocyclic compounds and pharmaceutical compositions containing the same
DE69430699D1 (de) Medikamente abgebende stents
DK0966277T3 (da) Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom
SE9504662D0 (sv) New compounds
EP1121932A4 (en) DRUGS FOR EYE DISEASES
CA2260863A1 (en) Treatment of psychotic disorders
MY118384A (en) Benzocycloheptathiophene compounds
FI914923A (fi) Foerfarande foer framstaellning av 5,11 -dihydro-6h-dipyrido-/3,2-b:2',3'-e//1,4/diazepiner. knippe.
IT1296613B1 (it) Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.
KR930010200U (ko) 무좀, 습진방지용 발가락 밴드
KR940018814U (ko) 신의 조립식 굽
IT1266787B1 (it) Composizioni terapeutiche ad attivita' antitumorale a base di derivati 1,3,8,10 tetrasostituiti del 4,5,6,7-tetratiocino-(1,2-b: 3,4-b')-
ITMI930017A0 (it) Composizione polimerizzabile per l'impreganzione di un supporto tessile, avente elevate caratteristiche tixotropiche
KR950000184U (ko) 신의 조립식 굽
FR2714058B1 (fr) Dérivés de 1,3-dioxane trisubstitués, leur préparation et leur application en thérapeutique.
ITMI930630A0 (it) Procedimento per la copolimerizzazione dell'etilene
ITTO950034A0 (it) Tavolo per la pratica di attivita' sportive.